Balchem Corp (BCPC) shareholders
Close on Nov 17, 2026Market cap $5.39BP/E 31.9Yield 0.57%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 4,688,457 | 14.40% | 13G (passive) amendment | Jun 30, 2025 |
| Vanguard Portfolio Management | 2,221,969 | 6.93% | 13G (passive) | Mar 31, 2026 |
| APG Group Joint filing with APG Asset Management US Inc. (6.10%), APG Asset Management, N.V. (6.10%) and 1 more | 1,993,527 | 6.10% | 13G (passive) amendment | Dec 31, 2024 |
| Vanguard Capital Management | 1,680,971 | 5.24% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BCPC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,964,479 | 15.62% | $838.75M | +122,882 | 0.01% |
| Vanguard Portfolio Management LLC | 2,221,267 | 6.99% | $375.28M | +27,850 | 0.02% |
| Vanguard Capital Management LLC | 1,445,369 | 4.55% | $244.20M | +13,281 | 0.01% |
| State Street Corp | 1,281,552 | 4.03% | $216.52M | +40,816 | 0.01% |
| Geode Capital Management, LLC | 1,122,146 | 3.53% | $189.61M | +74,947 | 0.01% |
| Conestoga Capital Advisors, LLC | 1,087,871 | 3.42% | $183.80M | −163,318 | 4.00% |
| Wasatch Advisors LP | 1,050,780 | 3.31% | $177.53M | −372,644 | 1.16% |
| Morgan Stanley | 834,445 | 2.63% | $140.98M | −22,924 | 0.01% |
| Geneva Capital Management LLC | 683,102 | 2.15% | $115.41M | −163,393 | 2.65% |
| First Trust Advisors LP | 617,233 | 1.94% | $104.28M | +163,896 | 0.06% |
| Dimensional Fund Advisors LP | 610,047 | 1.92% | $103.07M | +13,319 | 0.02% |
| FMR LLC | 560,255 | 1.76% | $94.66M | −38,415 | 0.00% |
| Congress Asset Management Co /Ma | 502,571 | 1.58% | $84.91M | +56,758 | 0.52% |
| Two Sigma Investments, LP | 502,038 | 1.58% | $84.82M | +71,828 | 0.06% |
| Schroder Investment Management Group | 440,418 | 1.39% | $74.52M | +79,922 | 0.05% |
| Nuveen, LLC | 414,367 | 1.30% | $70.01M | +20,882 | 0.02% |
| Norges Bank | 411,876 | 1.30% | $69.59M | New | 0.01% |
| Northern Trust Corp | 384,172 | 1.21% | $64.91M | +10,188 | 0.01% |
| Charles Schwab Investment Management Inc | 374,613 | 1.18% | $63.29M | +5,150 | 0.01% |
| JPMorgan Chase & Co | 341,653 | 1.08% | $58.06M | −85,346 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 416 | 29M | 91.3% | 49 / 141 | 161 / 47 | 2M | 2M |
| Q1 2026 | 424 | 29M | 90.0% | 61 / 157 | 138 / 40 | 6M | 2M |
| Q4 2025 | 409 | 29M | 90.3% | 52 / 148 | 150 / 40 | 2M | 2M |
| Q3 2025 | 406 | 29M | 92.1% | 46 / 143 | 152 / 30 | 2M | 2M |
| Q2 2025 | 396 | 29M | 91.8% | 54 / 156 | 123 / 37 | 2M | 2M |
| Q1 2025 | 382 | 29M | 91.6% | 57 / 139 | 124 / 29 | 2M | 2M |
| Q4 2024 | 359 | 29M | 91.6% | 42 / 137 | 111 / 36 | 1M | 2M |
| Q3 2024 | 358 | 30M | 93.4% | 45 / 132 | 117 / 18 | 6M | 1M |
| Q2 2024 | 334 | 30M | 92.8% | 42 / 120 | 115 / 25 | 1M | 2M |
| Q1 2024 | 320 | 31M | 96.9% | 43 / 108 | 116 / 15 | 2M | 1M |
| Q4 2023 | 292 | 30M | 94.2% | 39 / 95 | 106 / 36 | 2M | 1M |
| Q3 2023 | 293 | 29M | 90.1% | 32 / 104 | 106 / 19 | 1M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
370 funds held BCPC in Q2 2026, 54% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BCPC | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 1,935,679 | 6.09% | $327.03M | 0.29% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,018,611 | 3.21% | $172.09M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 846,327 | 2.66% | $142.99M | 0.17% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 737,004 | 2.32% | $124.52M | 0.07% | Jun 30, 2026 |
| First Trust SMID Cap Rising Dividend Achievers ETF | 565,174 | 1.78% | $95.49M | 0.84% | Jun 30, 2026 |
| Conestoga Small Cap Fund | 508,950 | 1.60% | $85.99M | 4.21% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 425,372 | 1.34% | $71.87M | 0.15% | Jun 30, 2026 |
| Wasatch Core Growth Fund | 411,133 | 1.29% | $69.46M | 2.33% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 368,410 | 1.16% | $62.24M | 0.06% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 357,739 | 1.13% | $59.94M | 0.18% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 294,416 | 0.93% | $49.74M | 0.29% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 285,666 | 0.90% | $48.26M | 0.31% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 274,506 | 0.86% | $43.02M | 0.02% | May 31, 2026 |
| Congress Small Cap Growth Fund | 250,000 | 0.79% | $41.89M | 2.09% | Jul 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 211,028 | 0.66% | $35.65M | 0.31% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Theodore L. Harris | Chairman, President & CEO, Director | 94,403 | 0.30% | Feb 13, 2026 |
| Ren Anthony Gonzalez | SVP and Chief R&D Officer | 7,219 | 0.02% | Sep 24, 2026 |
| Erin Leigh Gilson | Chief Accounting Officer | 2,486 | 0.01% | Apr 7, 2026 |
| Gunsteren Job Leonard van | SVP and GM, Specialty Products | 10,149 | 0.03% | Feb 13, 2026 |
| Hatsuki Miyata | EVP, CLO, & Secretary | 9,232 | 0.03% | Feb 13, 2026 |
| Frederic Boned | SVP/GM, Human Nutri. & Health | 9,419 | 0.03% | Feb 13, 2026 |
| Carl Martin Bengtsson | EVP & Chief Financial Officer | 29,012 | 0.09% | Feb 13, 2026 |
| George Graham | SVP and Chief R&D Officer | 3,220 | 0.01% | Feb 13, 2026 |
| William A. Backus | VP & Chief Accounting Officer | 7,019 | 0.02% | Feb 13, 2026 |
| Martin Luther Reid | SVP Chief Supply Chain Officer | 9,615 | 0.03% | Feb 13, 2026 |
| Michael Brent Tignor | SVP & Chief HR Officer | 12,179 | 0.04% | Feb 13, 2026 |
| Michael Robert Sestrick | SVP & Chief Technology Officer | 5,610 | 0.02% | Feb 14, 2025 |
| David B. Fischer | Director | 9,859 | 0.03% | Feb 13, 2026 |
| Matthew David Wineinger | Director | 8,012 | 0.03% | Feb 13, 2026 |
| Daniel E. Knutson | Director | 6,899 | 0.02% | Feb 13, 2026 |
| Monica Vicente | Director | 2,390 | 0.01% | Feb 13, 2026 |
| Olivier Rigaud | Director | 2,390 | 0.01% | Feb 13, 2026 |
| Kathleen B. Fish | Director | 3,429 | 0.01% | Feb 13, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Frederic Boned SVP/GM, Human Nutri. & Health | Feb 12, 2026 | Tax withholding | −203 | $177.49 | $36.03K | 8,978 |
| Carl Martin Bengtsson EVP & Chief Financial Officer | Feb 12, 2026 | Tax withholding | −302 | $177.49 | $53.60K | 27,926 |
| William A. Backus VP & Chief Accounting Officer | Feb 12, 2026 | Tax withholding | −70 | $177.49 | $12.42K | 6,736 |
| Theodore L. Harris Chairman, President & CEO, Director | Feb 12, 2026 | Tax withholding | −844 | $177.49 | $149.80K | 91,373 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Feb 12, 2026 | Tax withholding | −58 | $177.49 | $10.29K | 10,149 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Feb 12, 2026 | Tax withholding | −116 | $177.49 | $20.59K | 9,073 |
| Hatsuki Miyata EVP, CLO, & Secretary | Feb 12, 2026 | Tax withholding | −181 | $177.49 | $32.13K | 8,745 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 12, 2026 | Tax withholding | −165 | $177.49 | $29.29K | 10,723 |
| Olivier Rigaud Director | Feb 11, 2026 | Award | +870 | – | – | 2,390 |
| David B. Fischer Director | Feb 11, 2026 | Award | +870 | – | – | 8,859 |
| Frederic Boned SVP/GM, Human Nutri. & Health | Feb 11, 2026 | Tax withholding | −1,151 | $178.68 | $205.66K | 9,181 |
| Frederic Boned SVP/GM, Human Nutri. & Health | Feb 11, 2026 | Award | +2,247 | – | – | 10,332 |
| Frederic Boned SVP/GM, Human Nutri. & Health | Feb 11, 2026 | Award | +2,870 | – | – | 8,085 |
| Matthew David Wineinger Director | Feb 11, 2026 | Award | +870 | – | – | 8,012 |
| Carl Martin Bengtsson EVP & Chief Financial Officer | Feb 11, 2026 | Tax withholding | −2,416 | $178.68 | $431.69K | 28,228 |
| Carl Martin Bengtsson EVP & Chief Financial Officer | Feb 11, 2026 | Award | +3,610 | – | – | 25,926 |
| Carl Martin Bengtsson EVP & Chief Financial Officer | Feb 11, 2026 | Award | +4,718 | – | – | 30,644 |
| George Graham SVP and Chief R&D Officer | Feb 11, 2026 | Award | +700 | – | – | 3,200 |
| William A. Backus VP & Chief Accounting Officer | Feb 11, 2026 | Award | +490 | – | – | 6,007 |
| William A. Backus VP & Chief Accounting Officer | Feb 11, 2026 | Award | +1,664 | – | – | 7,671 |
| William A. Backus VP & Chief Accounting Officer | Feb 11, 2026 | Tax withholding | −865 | $178.68 | $154.56K | 6,806 |
| Theodore L. Harris Chairman, President & CEO, Director | Feb 11, 2026 | Award | +18,291 | – | – | 101,575 |
| Theodore L. Harris Chairman, President & CEO, Director | Feb 11, 2026 | Tax withholding | −9,358 | $178.68 | $1.67M | 92,217 |
| Theodore L. Harris Chairman, President & CEO, Director | Feb 11, 2026 | Award | +7,350 | – | – | 83,284 |
| Kathleen B. Fish Director | Feb 11, 2026 | Award | +870 | – | – | 3,429 |
| Daniel E. Knutson Director | Feb 11, 2026 | Award | +870 | – | – | 6,899 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Feb 11, 2026 | Award | +1,345 | – | – | 10,963 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Feb 11, 2026 | Tax withholding | −756 | $178.68 | $135.08K | 10,207 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Feb 11, 2026 | Award | +430 | – | – | 9,618 |
| Monica Vicente Director | Feb 11, 2026 | Award | +870 | – | – | 2,390 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Feb 11, 2026 | Award | +2,359 | – | – | 10,274 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Feb 11, 2026 | Tax withholding | −1,085 | $178.68 | $193.87K | 9,189 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Feb 11, 2026 | Award | +940 | – | – | 7,915 |
| Hatsuki Miyata EVP, CLO, & Secretary | Feb 11, 2026 | Award | +1,710 | – | – | 7,556 |
| Hatsuki Miyata EVP, CLO, & Secretary | Feb 11, 2026 | Tax withholding | −877 | $178.68 | $156.70K | 8,926 |
| Hatsuki Miyata EVP, CLO, & Secretary | Feb 11, 2026 | Award | +2,247 | – | – | 9,803 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 11, 2026 | Award | +1,929 | – | – | 11,879 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 11, 2026 | Award | +1,200 | – | – | 9,950 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 11, 2026 | Tax withholding | −991 | $178.68 | $177.07K | 10,888 |
| Carl Martin Bengtsson EVP & Chief Financial Officer | Feb 8, 2026 | Tax withholding | −863 | $173.16 | $149.44K | 22,316 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 8, 2026 | Tax withholding | −373 | $173.16 | $64.59K | 8,750 |
| Frederic Boned SVP/GM, Human Nutri. & Health | Feb 8, 2026 | Tax withholding | −430 | $173.16 | $74.46K | 5,215 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Feb 8, 2026 | Tax withholding | −416 | $173.16 | $72.03K | 6,975 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Feb 8, 2026 | Tax withholding | −258 | $173.16 | $44.68K | 9,188 |
| Theodore L. Harris Chairman, President & CEO, Director | Feb 8, 2026 | Tax withholding | −3,225 | $173.16 | $558.44K | 75,934 |
| William A. Backus VP & Chief Accounting Officer | Feb 8, 2026 | Tax withholding | −322 | $173.16 | $55.76K | 5,517 |
| Hatsuki Miyata EVP, CLO, & Secretary | Feb 8, 2026 | Tax withholding | −343 | $173.16 | $59.39K | 5,846 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Dec 4, 2025 | Sale | −1,765 | $153.80 | $271.46K | 9,446 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Dec 4, 2025 | Sale | −4,235 | $153.07 | $648.25K | 11,211 |
| Gunsteren Job Leonard van SVP and GM, Specialty Products | Dec 4, 2025 | Option exercise | +6,000 | $60.85 | $365.10K | 15,446 |
| David B. Fischer Director | Dec 3, 2025 | Sale | −6,000 | $153.91 | $923.46K | 9,989 |
| David B. Fischer Director | Dec 3, 2025 | Option exercise | +3,383 | $74.57 | $252.27K | 13,372 |
| David B. Fischer Director | Dec 3, 2025 | Option exercise | +2,617 | $84.09 | $220.06K | 15,989 |
| David B. Fischer Director | Dec 3, 2025 | Sale | −2,000 | $154.15 | $308.30K | 7,989 |
| Martin Luther Reid SVP Chief Supply Chain Officer | Nov 11, 2025 | Sale | −1,200 | $154.44 | $185.33K | 7,391 |
| Frederic Boned SVP/GM, Human Nutri. & Health | Oct 31, 2025 | Tax withholding | −1,085 | $153.39 | $166.43K | 5,645 |
| George Graham SVP and Chief R&D Officer | Oct 20, 2025 | Award | +2,500 | – | – | 2,500 |
| Hatsuki Miyata EVP, CLO, & Secretary | Jul 25, 2025 | Tax withholding | −483 | $148.82 | $71.88K | 6,189 |
| William A. Backus VP & Chief Accounting Officer | Apr 1, 2025 | Tax withholding | −383 | $167.24 | $64.05K | 5,839 |
| Michael Brent Tignor SVP & Chief HR Officer | Feb 13, 2025 | Tax withholding | −1,156 | $163.14 | $188.59K | 9,123 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Balchem's stock actually held short. Settlement fails (shares not delivered on time) peaked at 95 shares on Sep 2, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| David B. Fischer Director | Dec 8, 2025 | 2,000 | $308.40K | Dec 3, 2025 | Restricted Stock Awards |
| Gunsteren Job Leonard van Officer | Dec 4, 2025 | 6,000 | $919.72K | Dec 4, 2025 | Employee Stock Option Exercise |
| David B. Fischer Director | Dec 3, 2025 | 2,000 | $308.40K | Dec 3, 2025 | Option Exercise |
| David B. Fischer Director | Dec 3, 2025 | 6,000 | $923.46K | Dec 3, 2025 | Stock Option Exercise |
| Martin Luther Reid Officer | Nov 12, 2025 | 1,200 | $185.33K | Nov 11, 2025 | Vesting of Performance Stock Unit |
| Joyce J. Lee Former Director | Nov 6, 2024 | 4,476 | $809.57K | Nov 6, 2024 | Stock Option Exercise |
| Joyce J. Lee Former Director | Nov 5, 2024 | 2,000 | $350.00K | Nov 5, 2024 | Stock Option Exercise |
| Gunsteren Job Leonard van Officer | Jul 31, 2024 | 7,750 | $1.40M | Jul 31, 2024 | Employee Stock Option Exercise |
| William A. Backus Officer | Jul 30, 2024 | 3,900 | $699.47K | Jul 30, 2024 | Employee Stock Option Exercise |
| Jonathan Harrison Griffin Former Officer | May 24, 2024 | 2,500 | $383.95K | May 24, 2024 | Employee Stock Option Exercise |
| Jonathan Harrison Griffin Former Officer | May 21, 2024 | 1,500 | $232.48K | May 21, 2024 | Employee Stock Option Exercise |
| Michael Robert Sestrick Officer | May 10, 2024 | 1,929 | $297.93K | May 10, 2024 | Vesting of Performance Stock Unit |
| David B. Fischer Director | May 8, 2024 | 5,000 | $766.40K | May 8, 2024 | Vesting Shares |
| Michael Brent Tignor Officer | Mar 8, 2024 | 5,339 | $840.99K | Mar 8, 2024 | Vesting of Restricted Stock Units |
| Matthew David Wineinger Director | Mar 4, 2024 | 1,333 | $209.13K | Mar 4, 2024 | Vesting of Restricted Stock Units |
Congress trades
6 trades in Balchem reported by 3 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | Bought | Sep 17, 2026 | $1K–15K | Oct 12, 2026 |
| Gilbert Cisneros CA31 | Bought | Jul 10, 2026 | $1K–15K | Sep 4, 2026 56 days late |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Apr 9, 2025 | $1K–15K | May 14, 2025 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Dec 2, 2021 | $1K–15K | Jan 10, 2022 |
| Gilbert Cisneros CA31 | Bought | May 21, 2020 | $1K–15K | Jun 16, 2020 |
| Donna Shalala FL27 | Sold | Jun 24, 2019 | $1K–15K | Apr 27, 2020 308 days late |
See a number that looks wrong?